Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 2,900.00
+75.00 (2.65%)
At close: Apr 17, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 33.81 billion as of April 17, 2026. Its market cap has decreased by -11.85% in one year.
Market Cap
33.81B
Enterprise Value
41.26B
Revenue
52.15B
Ranking
n/a
PE Ratio
44.86
Stock Price
2,900.00
Market Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 33.81B, an increase of 69.06%. That is a compound annual growth rate of 2.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 33.81B | -5.84% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RP Bio | 55.46B |
| Eagle Veterinary Technology Co.,Ltd | 50.25B |
| Korean Drug | 46.05B |
| HLscience | 42.22B |
| GeneBioTech Co. ,Ltd | 42.06B |
| ChoA Pharmaceutical Co., LTD. | 30.17B |
| Daesung Microbiological Labs. | 29.26B |
| Pharmsville | 29.06B |